Getinge AB Price Target Lowered to €200.00 at UBS AG (GETI-B)
Equities researchers at UBS AG lowered their target price on shares of Getinge AB (STO:GETI-B) from €237.00 ($320.27) to €200.00 ($270.27) in a research report issued on Friday, AmericanBankingNews.com reports. The firm currently has a “neutral” rating on the stock.
Separately, analysts at Jefferies Group raised their price target on shares of Getinge AB from €180.00 ($243.24) to €190.00 ($256.76) in a research note to investors on Friday. They now have a “hold” rating on the stock.
Getinge AB is a Sweden-based company active in the healthcare sector. It is engaged in the provision of products and services for intensive care units, care units, sterilization centers, elderly care and companies and institutions active in the life sciences area.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.